A. Vu
发表
O. Elci,
M. Hogarty,
T. Laetsch,
2014,
Cell Death and Disease.
M. Hogarty,
S. Karageorgos,
C. Burudpakdee,
2022,
Oncoimmunology.
M. Hogarty,
S. Karageorgos,
A. Wolpaw,
2021,
bioRxiv.
K. Barald,
J. Germiller,
L. Bianchi,
2008
.
J. Maris,
C. Thompson,
M. Hogarty,
2012,
Cancer cell.
Kangning Liu,
M. Hogarty,
M. Haber,
2016,
Clinical Cancer Research.
M. Hogarty,
Huaqing Zhao,
C. Reynolds,
2022
.
Kangning Liu,
G. Hajnóczky,
M. Hogarty,
2022,
The EMBO journal.
Kangning Liu,
G. Hajnóczky,
M. Hogarty,
2021,
bioRxiv.
Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours.
J. Lunec,
M. Hogarty,
D. Tweddle,
2018,
International journal of oncology.
R. Nordon,
S. Shen,
T. O’Brien,
2019,
Cytotherapy.
M. Hogarty,
M. Wierer,
O. Panasenko,
2024,
bioRxiv.